Clinical Benefit of Second-Line Palliative Chemotherapy in Advanced Soft-Tissue Sarcoma

Table 5

Disease control rate of first-line chemotherapy against disease control rate of second-line chemotherapy.

		1st-line chemotherapy
		Responder	Non responder
2nd-line chemotherapy	Responder	42	28
	Non responder	130	145